BASF has received the Environmental Protection Agency (EPA) approval for the use of Aseptrol S10 – tab in H1N1 sanitisation operations in institutional and industrial facilities, such as, schools, hospitals, government buildings, retail and restaurants, and recreational facilities. Aseptrol S10 – tab is based on Chlorine dioxide (CIO2) release technology.
Reportedly, CIO2 is formed in the pores of the tablet when immersed in water. As the tablet dissolves, the powerful oxidizer disperses into the bulk solution.
The company claims that using Aseptrol S10 – tab is as easy as drop, spray and wipe. One can drop the tablet in a spray bottle containing water, spray it evenly on a non-porous surface and wipe the surface until dry. Treated surfaces must remain wet for 10 minutes (or 30 minutes for Foot and Mouth Disease Virus). The solution does not leave a residue.
Gary Dee, business director, home and personal care, care chemicals of North America at BASF, said: “Aseptrol S10 – tab delivers a broad spectrum disinfectant as stated in the EPA label and kills a large number of pathogens, such as H1N1 virus, Avian Influenza A (H3N2), Influenza A, and HIV, on contact surfaces. The tablet is stable when dry and is packed in foil pouches, saving energy and reducing overall logistics costs.”